[Excerpt] Executive Summary: The microalgae industry has a long history of technical promise outrunning commercial results. Decades of research, public funding, and venture capital have produced few sustainably profitable companies. The failures are rarely biological. They trace back to poor market selection, premature scale-up, and reliance on demand that never materialized. This plan analyzes an operating microalgae producer based in western Mexico (hereafter, “the company”) and proposes a growth strategy built on market pull rather than production push. The company manufactures a liquid Spirulina-based biofertilizer/biostimulant sold to horticultural producers in the state of Jalisco, with U.S. golf course contracts currently in advanced negotiation. Installed capacity is approximately 3,000 liters per month, while current sales sit near 500 liters per month. This leaves roughly 83% of installed capacity unused and is the single most important fact in the diagnosis: the binding constraint on growth is market access, not production.